IGF1 and cancer: Goal treatment IGF-I levels remain unclear (e.g., whether concern if above 0 SDS), but the consensus opinions for those undergoing GH treatment remain the same between the cancer population and non-cancer population and includes maintaining serum IGF-I levels within the normal range for age and pubertal status (2).